Reports Q3 revenue $262.9M, consensus $255.16M. “We delivered another strong quarter,” said Ken Burdick, Chairman and CEO of LifeStance. “In addition to solid financial results, we continued to attract high-quality clinical talent with a record quarter of organic recruiting, growing the team by nearly 300 clinicians. As we approach the end of the year, we will continue our commitment to improving the patient and clinician experience while continuing to fortify the company’s foundation to build long-term, scalable operations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LFST:
- LifeStance Reports Third Quarter 2023 Results
- Morgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth Prospects
- Morgan Stanley positive on LifeStance ahead of earnings
- Morgan Stanley sees ‘compelling entry point’ after LifeStance targeted by shorts
- LifeStance ‘represents the worst of the public markets,’ says The Bear Cave
